Tumor Immunotherapy Using A2A Adenosine Receptor Antagonists

被引：20
|
作者：
Zhang, Jinfeng [1 ,2 ]
Yan, Wenzhong [1 ]
Duan, Wenwen [1 ]
Wuthrich, Kurt [1 ,3 ]
Cheng, Jianjun [1 ]
机构：
[1] ShanghaiTech Univ, IHuman Inst, Shanghai 201210, Peoples R China
[2] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China
[3] Scripps Res, Dept Integrated Struct & Computat Biol, La Jolla, CA 92037 USA
来源：
PHARMACEUTICALS | 2020年 / 13卷 / 09期
关键词：
GPCR; immuno-oncology; Parkinson's disease; drug binding modes; cancer therapy; PARKINSONS-DISEASE; CRYSTAL-STRUCTURE; DERIVATIVES; ZM241385; POTENT; ZM-241385; BLOCKADE; BINDING; CELLS;
D O I：
10.3390/ph13090237
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The A(2A) adenosine receptor (A(2A) AR) plays critical roles in human physiology and pathophysiology, which makes it an important drug target. Previous drug-discovery efforts targeting the A(2A) AR have been focused on the use of A(2A) AR antagonists for the treatment of Parkinson's disease. More recently, the A(2A) AR has attracted additional attention for its roles in immuno-oncology, and a number of A(2A) AR antagonists are currently used as lead compounds for antitumor drugs in both preclinical models and clinical trials. This review surveys recent advances in the development of A(2A) AR antagonists for cancer immunotherapy. The therapeutic potential of representative A(2A) AR antagonists is discussed based on both animal efficacy studies and clinical data.
引用
收藏
页码：1 / 14
页数：14
相关论文
共 50 条
  • [21] Discovery of 2-aminoimidazopyridine adenosine A2A receptor antagonists
    McGuinness, Brian F.
    Cole, Andrew G.
    Dong, Guizhen
    Brescia, Marc-Raleigh
    Shao, Yuefei
    Henderson, Ian
    Rokosz, Laura L.
    Stauffer, Tara M.
    Mannava, Neelima
    Kimble, Earl F.
    Hicks, Catherine
    White, Nicole
    Wines, Pamela G.
    Quadros, Elizabeth
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (22) : 6845 - 6849
  • [22] Novel dual A2A A2B adenosine receptor antagonists for cancer immunotherapy: in vitro and in vivo characterization
    Galezowski, Michal
    Wegrzyn, Paulina
    Bobowska, Aneta
    Dziedzic, Katarzyna
    Szeremeta-Spisak, Joanna
    Nowogrodzki, Marcin
    Satala, Grzegorz
    Obara, Alicja
    Lozinska-Raj, Iwona
    Dudek, Marcelina
    Janiga, Anita
    Reus, Jacek
    Wronowski, Marek
    Zastawna, Magdalena
    Statkiewicz, Grzegorz
    Rogacki, Maciej
    Ziembik, Magdalena
    Grycuk, Karolina
    Soukou, Foteini
    Michalik, Kinga
    Adamus, Agnieszka
    Wiatrowska, Karolina
    Lewandowska, Natalia
    Golas, Aniela
    Haberkiewicz, Olga
    Porter, Rod
    Brzozka, Krzysztof
    Nowak, Mateusz
    CANCER RESEARCH, 2019, 79 (13)
  • [23] Discovery of Pyridinone Derivatives as Potent, Selective, and Orally Bioavailable Adenosine A2A Receptor Antagonists for Cancer Immunotherapy
    Zhu, Chenyu
    Ze, Shuyin
    Zhou, Ronghui
    Yang, Xinyu
    Wang, Haojie
    Chai, Xiaolei
    Fang, Meimiao
    Liu, Mingyao
    Wang, Yonghui
    Lu, Weiqiang
    Xie, Qiong
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (07) : 4734 - 4754
  • [24] Potential of adenosine A2A receptor antagonists in the treatment of movement disorders
    Mally, J
    Stone, TW
    CNS DRUGS, 1998, 10 (05) : 311 - 320
  • [25] Discovery of aminoquinazoline derivatives as human A2A adenosine receptor antagonists
    Zhou, Gang
    Aslanian, Robert
    Gallo, Gioconda
    Khan, Tanweer
    Kuang, Rongze
    Purakkattle, Biju
    De Ruiz, Manuel
    Stamford, Andrew
    Ting, Pauline
    Wu, Heping
    Wang, Hongwu
    Xiao, Dong
    Yu, Tao
    Zhang, Yonglian
    Mullins, Deborra
    Hodgson, Robert
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (04) : 1348 - 1354
  • [26] Adenosine A2A receptor antagonists in the therapy of Parkinson's disease
    Morelli, M.
    Simola, N.
    Pinna, A.
    Pontis, S.
    BEHAVIOURAL PHARMACOLOGY, 2006, 17 (5-6): : 537 - 537
  • [27] Triamino derivatives of triazolotriazine and triazolopyrimidine as adenosine A2a receptor antagonists
    Vu, CB
    Shields, P
    Peng, B
    Kumaravel, G
    Jin, XW
    Phadke, D
    Wang, J
    Engber, T
    Ayyub, E
    Petter, RC
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (19) : 4835 - 4838
  • [28] Computational studies of the binding modes of A2A adenosine receptor antagonists
    Y. Ye
    J. Wei
    X. Dai
    Q. Gao
    Amino Acids, 2008, 35 : 389 - 396
  • [29] Recent advances in the design and optimization of adenosine A2A receptor antagonists
    Vu, CB
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2005, 8 (04) : 458 - 468
  • [30] Computational studies of the binding modes of A2A adenosine receptor antagonists
    Ye, Y.
    Wei, J.
    Dai, X.
    Gao, Q.
    AMINO ACIDS, 2008, 35 (02) : 389 - 396
12345